Cargando…
Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202285/ https://www.ncbi.nlm.nih.gov/pubmed/34136414 http://dx.doi.org/10.3389/fonc.2021.707608 |
| _version_ | 1783707949565214720 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8202285 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82022852021-06-15 Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway Front Oncol Oncology Frontiers Media S.A. 2021-05-31 /pmc/articles/PMC8202285/ /pubmed/34136414 http://dx.doi.org/10.3389/fonc.2021.707608 Text en Copyright © 2021 Frontiers Editorial Office https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
| title | Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
| title_full | Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
| title_fullStr | Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
| title_full_unstemmed | Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
| title_short | Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
| title_sort | retraction: inhibitor 9 combined with androgen deprivation therapy or chemotherapy delays the malignant behavior of castration-resistant prostate cancer through k-ras/plcϵ/pkcϵ signaling pathway |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202285/ https://www.ncbi.nlm.nih.gov/pubmed/34136414 http://dx.doi.org/10.3389/fonc.2021.707608 |
| work_keys_str_mv | AT retractioninhibitor9combinedwithandrogendeprivationtherapyorchemotherapydelaysthemalignantbehaviorofcastrationresistantprostatecancerthroughkrasplcepkcesignalingpathway |